Activating pyruvate kinase R
US-12128035-B2 · Oct 29, 2024 · US
This page is not indexed by search engines while we improve data quality.
Richard David patents
Richard David is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Richard David |
| Total patents | 30 |
| First publication | Nov 28, 2019 |
| Latest publication | Oct 29, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Activating pyruvate kinase R
US-12122778-B2 · Oct 22, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-12071440-B2 · Aug 27, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-12053458-B2 · Aug 6, 2024 · US
Treating sickle cell disease with a pyruvate kinase R activating compound
US-11980611-B2 · May 14, 2024 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2024083901-A1 · Mar 14, 2024 · US
Activating pyruvate kinase R
US-11844787-B2 · Dec 19, 2023 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2023381151-A1 · Nov 30, 2023 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11649242-B2 · May 16, 2023 · US
Activating pyruvate kinase r
US-2023055923-A1 · Feb 23, 2023 · US
Recent patents
Latest publications not already listed above.
Activating pyruvate kinase r
US-2022378756-A1 · Dec 1, 2022 · US
Activating pyruvate kinase r
US-2022304987-A1 · Sep 29, 2022 · US
Activating pyruvate kinase r
US-2022087983-A1 · Mar 24, 2022 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2022031671-A1 · Feb 3, 2022 · US
Activating pyruvate kinase r
US-2021308108-A1 · Oct 7, 2021 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2021246143-A1 · Aug 12, 2021 · US
Activating pyruvate kinase R
US-11071725-B2 · Jul 27, 2021 · US
Activating pyruvate kinase r and mutants thereof
US-2021221816-A1 · Jul 22, 2021 · US
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
US-11014927-B2 · May 25, 2021 · US
Activating pyruvate kinase R and mutants thereof
US-11001588-B2 · May 11, 2021 · US
Thienopyridine carboxamides as ubiquitin-specific protease inhibitors
US-10913753-B2 · Feb 9, 2021 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2020405699-A1 · Dec 31, 2020 · US
Activating pyruvate kinase r
US-2020253939-A1 · Aug 13, 2020 · US
Activating pyruvate kinase R
US-10675274-B2 · Jun 9, 2020 · US
Treating sickle cell disease with a pyruvate kinase r activating compound
US-2020129485-A1 · Apr 30, 2020 · US
Activating pyruvate kinase r and mutants thereof
US-2020087309-A1 · Mar 19, 2020 · US
Activating pyruvate kinase r
US-2020085798-A1 · Mar 19, 2020 · US
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
US-2020069643-A1 · Mar 5, 2020 · US
Thienopyridine Carboxamides as Ubiquitin-Specific Protease Inhibitors
US-2020017525-A1 · Jan 16, 2020 · US
Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors
US-2019359628-A1 · Nov 28, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Forma Therapeutics Inc | 24 |
| Novo Nordisk Healthcare Ag | 6 |
| Valo Early Discovery Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K9/0053 | 24 |
| C07D487/04 | 23 |
| A61K31/436 | 22 |
| A61P7/06 | 13 |
| A61K9/2054 | 13 |